Evidence map›Paper›PMID 37809411›Full record

ArticleHeliyon2023

Nitroglycerin trapping in melamine matrices.

Cédric Schwartz, Marc Comet, Bastien Lallemand, Maxence Vince, Anna K Ott, Fabien Schnell, Benjamin Bonnet, Denis Spitzer

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cédric SchwartzNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Marc CometNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Bastien LallemandNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Maxence VinceNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Anna K OttNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Fabien SchnellNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Benjamin BonnetNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Denis SpitzerNS3E Laboratory - UMR 3208 (ISL-CNRS-UNISTRA), French-German Research Institute of Saint-Louis, BP 70034, 68301 Saint Louis Cedex, France.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melamine (Mel) was used as host matrix for liquid nitroglycerin (NG), to prepare Mel/NG solid powdered compounds containing up to 45 wt% of this explosive. The two preparation processes used for this purpose consisted in evaporating a solution of both components, either in ambient conditions or under reduced pressure by the Spray Flash-Evaporation (SFE) process. In Mel/NG materials, amorphous nitroglycerin is distributed in the crystallized melamine matrix as inclusions, which were found to be smaller in size in the material prepared by the SFE process. Mel/NG materials are not stable over time: they gradually lose the nitroglycerin they contain by evaporation.

Indexed as

CompositeExplosiveInclusionMatrixMelamineNitroglycerin

Identifiers

PMID37809411
PMCPMC10560045
OpenAlexW4386851451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.